Details of the Drug Reposition
General Information of This Drug (ID: DMETVFJ)
Drug Name | ||||||
---|---|---|---|---|---|---|
Synonyms | Xolair; Omalizumab (genetical recombination); Xolair (TN); Omalizumab (USAN/INN); Omalizumab (genetical recombination) (JAN) | |||||
Therapeutic Class |
Antiasthmatic Agents
|
|||||
Drug Type |
Monoclonal antibody
|
|||||
Information on Drug Reposition of This Drug
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 Approved Indication(s)
|
|
|||||||||||||||||||||||||
1 Phase 2 Indication(s)
|
|
|||||||||||||||||||||||||